ArticleBMJ global health2026
An analysis of national guidelines for the prevention, diagnosis and treatment of cryptococcal meningitis in sub-Saharan African countries: gaps and opportunities.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% of AIDS-related mortality worldwide, with the highest burden being in sub-Saharan Africa (SSA). In 2022, the WHO released clinical guidelines on the prevention, diagnosis and treatment of CM, based on strong evidence-based studies. It is not known how these WHO guidelines are being integrated at the national level. This study aims to highlight national clinical guidelines for the prevention, diagnosis and management of CM across SSA and how these guidelines compare to WHO 2022 CM guidelines.
methodsA comprehensive search was conducted to gather the current national clinical CM guidelines from all 46 countries in SSA. Methods to acquire copies of national guidelines included using online search engines, official government websites, WHO country office websites, direct contact with WHO officials and officers in national ministries of health as well as surveying the data repository of the International AIDS Society and HIV Policy Lab's Advanced HIV Disease Dashboard. National CM guidelines were analysed to determine if they incorporated the recommendations in the 2022 WHO CM guidelines.
resultsOf the 46 countries in SSA, 37% (17/46) did not have established national CM screening and diagnostic guidelines and 35% (16/46) did not have established national CM treatment guidelines accessible through our methodology. Among the countries with CM guidelines, 21% (10/46) follow WHO recommendations for prevention, 30% (14/46) for diagnosis and 13% (6/46) for treatment.
conclusionDespite recent evidence to support diagnostic techniques and treatment approaches to improve CM outcomes, most national CM guidelines in SSA are not in accordance with the updated WHO recommendations, stressing a persistent gap in national adoption of CM international evidence-based guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.